Iams, MD, MSCI, discussed potential ways to determine which patients benefit most from additional therapy for extensive-stage ...

Lutetium Lu 177 vipivotide tetraxetan combined with ARPI and ADT improved rPFS in PSMA-positive mHSPC patients compared to ARPI and ADT alone. Lutetium Lu 177 vipivotide tetraxetan significantly ...

In this video, Leo I. Gordon, MD, FACP, discusses highlights from a debate at Lymphoma, Leukemia & Myeloma Congress on the evolving treatment landscape for relapsed or refractory diffuse large B-cell ...

A study led by André Veillette, a researcher at the Montreal Clinical Research Institute (IRCM) and a professor in the ...

Those silver strands could be an outward sign of the body’s own intricate defences against cancer, a recent study in mice has ...

Researchers can use messenger RNA to trigger the immune system to attack tumors. By stimulating cancer cells to produce a ...

A grieving daughter is battling to ensure families don’t have to go through the battles she fought for her dad who died of pancreatic cancer in June. His death aged 61 came just a few weeks after ...

This Research Topic seeks to advance the understanding of the complex, bidirectional relationship between cardiometabolic risk factors and cancer. The ...

Cannabidiol (CBD) inhibits tumor growth in triple-negative breast cancer (TNBC), a highly aggressive form that lacks targeted ...

Joshua K. Sabari, MD, director of High Reliability Organization Initiatives at NYU Langone Health's Perlmutter Cancer Center, ...

Tumors were eradicated in 30% of mice receiving cGAS LNPs injected into the tumor, in combination with immune checkpoint blockade.

A research team from the Department of Bioscience, Faculty of Life Sciences, Okayama University of Science, has made a ...